Endometriosis Drugs Market Report

China Endometriosis Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 16, 2023
  • PAGES：205
  • REPORT CODE：GMM1800479
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Endometriosis Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Teva Pharmaceutical Industries Ltd

    • Johnson & Johnson Services Inc

    • Bayer AG

    • AstraZeneca Plc

    • Pfizer Inc

    • Merck & Co, Inc

    • AbbVie Inc

    • Takeda Pharmaceutical Co Ltd

    • Allergan Plc

    By Type:

    • Others

    • Progestin

    • Gonadotropins Releasing Hormone Agonists (GnRH)

    • Oral Contraceptive Pills

    • Non-Steroidal Anti-Inflammatory Drugs

    By Application:

    • Parenteral

    • Oral

    • Other RoA

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Endometriosis Drugs Market Overview 2018-2029

    • 1.1 China Endometriosis Drugs Industry Development Overview

    • 1.2 China Endometriosis Drugs Industry Development History

    • 1.3 China Endometriosis Drugs Industry Market Size (2018-2029)

    • 1.4 China Endometriosis Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Progestin (2018-2029)

      • 1.4.3 China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Gonadotropins Releasing Hormone Agonists (GnRH) (2018-2029)

      • 1.4.4 China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Oral Contraceptive Pills (2018-2029)

      • 1.4.5 China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)

    • 1.5 China Endometriosis Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Endometriosis Drugs Sales Volume, Sales Value and Growth Rate of Parenteral (2018-2029)

      • 1.5.2 China Endometriosis Drugs Sales Volume, Sales Value and Growth Rate of Oral (2018-2029)

      • 1.5.3 China Endometriosis Drugs Sales Volume, Sales Value and Growth Rate of Other RoA (2018-2029)

    • 1.6 China Endometriosis Drugs Market Analysis by Region

      • 1.6.1 North China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Endometriosis Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Endometriosis Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Endometriosis Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Endometriosis Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Endometriosis Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Endometriosis Drugs Industry Development

    Chapter 3 Endometriosis DrugsIndustry Chain Analysis

    • 3.1 Endometriosis Drugs Industry Chain

    • 3.2 Endometriosis Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Endometriosis Drugs Market

    • 3.3 Endometriosis Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Endometriosis Drugs Market

    Chapter 4 China Endometriosis Drugs Market, by Type

    • 4.1 China Endometriosis Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Endometriosis Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Endometriosis Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Endometriosis Drugs Production Volume and Growth Rate of Others

      • 4.5.2 China Endometriosis Drugs Production Volume and Growth Rate of Progestin

      • 4.5.3 China Endometriosis Drugs Production Volume and Growth Rate of Gonadotropins Releasing Hormone Agonists (GnRH)

      • 4.5.4 China Endometriosis Drugs Production Volume and Growth Rate of Oral Contraceptive Pills

      • 4.5.5 China Endometriosis Drugs Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs

    Chapter 5 China Endometriosis Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Endometriosis Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Endometriosis Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Endometriosis Drugs Market Size and Growth Rate of Parenteral

      • 5.5.2 China Endometriosis Drugs Market Size and Growth Rate of Oral

      • 5.5.3 China Endometriosis Drugs Market Size and Growth Rate of Other RoA

    Chapter 6 China Endometriosis Drugs Market, by Region

    • 6.1 China Endometriosis Drugs Production Volume and Production Value, by Region

    • 6.2 China Endometriosis Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Endometriosis Drugs Market Analysis

    • 7.1 North China Endometriosis Drugs Market, by Type

    • 7.2 North China Endometriosis Drugs Market, by Application

    Chapter 8 Central China Endometriosis Drugs Market Analysis

    • 8.1 Central China Endometriosis Drugs Market, by Type

    • 8.2 Central China Endometriosis Drugs Market, by Application

    Chapter 9 South China Endometriosis Drugs Market Analysis

    • 9.1 South China Endometriosis Drugs Market, by Type

    • 9.2 South China Endometriosis Drugs Market, by Application

    Chapter 10 East China Endometriosis Drugs Market Analysis

    • 10.1 East China Endometriosis Drugs Market, by Type

    • 10.2 East China Endometriosis Drugs Market, by Application

    Chapter 11 Northeast China Endometriosis Drugs Market Analysis

    • 11.1 Northeast China Endometriosis Drugs Market, by Type

    • 11.2 Northeast China Endometriosis Drugs Market, by Application

    Chapter 12 Southwest China Endometriosis Drugs Market Analysis

    • 12.1 Southwest China Endometriosis Drugs Market, by Type

    • 12.2 Southwest China Endometriosis Drugs Market, by Application

    Chapter 13 Northwest China Endometriosis Drugs Market Analysis

    • 13.1 Northwest China Endometriosis Drugs Market, by Type

    • 13.2 Northwest China Endometriosis Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Teva Pharmaceutical Industries Ltd

        • 14.1.1 Teva Pharmaceutical Industries Ltd Company Profile

        • 14.1.2 Teva Pharmaceutical Industries Ltd Endometriosis Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Johnson & Johnson Services Inc

        • 14.2.1 Johnson & Johnson Services Inc Company Profile

        • 14.2.2 Johnson & Johnson Services Inc Endometriosis Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bayer AG

        • 14.3.1 Bayer AG Company Profile

        • 14.3.2 Bayer AG Endometriosis Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 AstraZeneca Plc

        • 14.4.1 AstraZeneca Plc Company Profile

        • 14.4.2 AstraZeneca Plc Endometriosis Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer Inc

        • 14.5.1 Pfizer Inc Company Profile

        • 14.5.2 Pfizer Inc Endometriosis Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Merck & Co, Inc

        • 14.6.1 Merck & Co, Inc Company Profile

        • 14.6.2 Merck & Co, Inc Endometriosis Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AbbVie Inc

        • 14.7.1 AbbVie Inc Company Profile

        • 14.7.2 AbbVie Inc Endometriosis Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Takeda Pharmaceutical Co Ltd

        • 14.8.1 Takeda Pharmaceutical Co Ltd Company Profile

        • 14.8.2 Takeda Pharmaceutical Co Ltd Endometriosis Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Allergan Plc

        • 14.9.1 Allergan Plc Company Profile

        • 14.9.2 Allergan Plc Endometriosis Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Endometriosis Drugs Industry Research Conclusions

    • 15.2 Endometriosis Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Endometriosis Drugs Industry Market Size (2018-2029)

    • Figure China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Progestin (2018-2029)

    • Figure China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Gonadotropins Releasing Hormone Agonists (GnRH) (2018-2029)

    • Figure China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Oral Contraceptive Pills (2018-2029)

    • Figure China Endometriosis Drugs Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)

    • Figure China Endometriosis Drugs Sales Volume, Sales Value and Growth Rate of Parenteral (2018-2029)

    • Figure China Endometriosis Drugs Sales Volume, Sales Value and Growth Rate of Oral (2018-2029)

    • Figure China Endometriosis Drugs Sales Volume, Sales Value and Growth Rate of Other RoA (2018-2029)

    • Figure North China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Endometriosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Endometriosis Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Endometriosis Drugs Market Share by Type in 2018

    • Figure China Endometriosis Drugs Market Share by Type in 2023

    • Figure China Endometriosis Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Endometriosis Drugs Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Endometriosis Drugs Production Volume and Growth Rate of Progestin (2018-2023)

    • Figure China Endometriosis Drugs Production Volume and Growth Rate of Gonadotropins Releasing Hormone Agonists (GnRH) (2018-2023)

    • Figure China Endometriosis Drugs Production Volume and Growth Rate of Oral Contraceptive Pills (2018-2023)

    • Figure China Endometriosis Drugs Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2023)

    • Figure China Endometriosis Drugs Market Share by Application in 2018

    • Figure China Endometriosis Drugs Market Share by Application in 2023

    • Figure China Endometriosis Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Parenteral (2018-2023)

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Oral (2018-2023)

    • Figure China Endometriosis Drugs Market Size and Growth Rate of Other RoA (2018-2023)

    • Table China Endometriosis Drugs Production Volume by Region (2018-2023)

    • Table China Endometriosis Drugs Production Volume Share by Region (2018-2023)

    • Figure China Endometriosis Drugs Production Volume Share by Region (2018-2023)

    • Table China Endometriosis Drugs Production Value by Region (2018-2023)

    • Table China Endometriosis Drugs Production Value Share by Region (2018-2023)

    • Figure China Endometriosis Drugs Production Value Share by Region (2018-2023)

    • Table China Endometriosis Drugs Sales Volume by Region (2018-2023)

    • Table China Endometriosis Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Endometriosis Drugs Sales Volume Share by Region (2018-2023)

    • Table China Endometriosis Drugs Sales Value by Region (2018-2023)

    • Table China Endometriosis Drugs Sales Value Share by Region (2018-2023)

    • Figure China Endometriosis Drugs Sales Value Share by Region (2018-2023)

    • Table North China Endometriosis Drugs Production Volume by Type (2018-2023)

    • Table North China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Table North China Endometriosis Drugs Sales Volume by Application (2018-2023)

    • Table North China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Endometriosis Drugs Production Volume by Type (2018-2023)

    • Table Central China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Endometriosis Drugs Sales Volume by Application (2018-2023)

    • Table Central China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Endometriosis Drugs Production Volume by Type (2018-2023)

    • Table South China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Table South China Endometriosis Drugs Sales Volume by Application (2018-2023)

    • Table South China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Endometriosis Drugs Production Volume by Type (2018-2023)

    • Table East China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Table East China Endometriosis Drugs Sales Volume by Application (2018-2023)

    • Table East China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Endometriosis Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Endometriosis Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Endometriosis Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Endometriosis Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Endometriosis Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Endometriosis Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Endometriosis Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Endometriosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd Company Profile

    • Table Teva Pharmaceutical Industries Ltd Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Services Inc Company Profile

    • Table Johnson & Johnson Services Inc Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Plc Company Profile

    • Table AstraZeneca Plc Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table AbbVie Inc Company Profile

    • Table AbbVie Inc Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Co Ltd Company Profile

    • Table Takeda Pharmaceutical Co Ltd Endometriosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Allergan Plc Company Profile

    • Table Allergan Plc Endometriosis Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US